{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:43:58Z","timestamp":1790502238548,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/infdis\/jix108","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T20:09:30Z","timestamp":1487966970000},"page":"S176-S182","source":"Crossref","is-referenced-by-count":41,"title":["Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission"],"prefix":"10.1093","volume":"216","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Kid Risk and"},{"name":"College of Medicine, University of Central Florida,Orlando"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"additional","affiliation":[{"name":"Kid Risk and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"key\n\t\t\t\t20180306121508_CIT0001","author":"UNICEF"},{"key":"key\n\t\t\t\t20180306121508_CIT0002","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","article-title":"Modeling population immunity to support efforts to end the transmission of live polioviruses","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180306121508_CIT0003","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1377\/hlthaff.28.4.1079","article-title":"Polio eradication: strengthening the weakest links","volume":"28","author":"Barrett","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"key\n\t\t\t\t20180306121508_CIT0004","doi-asserted-by":"crossref","first-page":"770","DOI":"10.15585\/mmwr.mm6530a4","article-title":"Environmental isolation of circulating vaccine-derived poliovirus after interruption of wild poliovirus transmission\u2014Nigeria, 2016","volume":"65","author":"Etsano","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306121508_CIT0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180306121508_CIT0006","first-page":"204","article-title":"Meeting of the strategic advisory group of experts on immunization, April 2012\u2014conclusions and recommendations, polio eradication","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121508_CIT0007","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/infdis\/jit845","article-title":"Modeling the dynamics of oral poliovirus vaccine cessation","volume":"210","author":"Thompson","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0008","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121508_CIT0009","first-page":"1031","article-title":"Possible eradication of wild poliovirus type 3\u2014worldwide, 2012","volume":"63","author":"Kew","year":"2014","journal-title":"Morb Mort Wkly Rep"},{"key":"key\n\t\t\t\t20180306121508_CIT0010","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121508_CIT0011","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3329\/jhpn.v27i3.3378","article-title":"Factors associated with missed vaccination during mass immunization campaigns","volume":"27","author":"Weiss","year":"2009","journal-title":"J Health Popul Nutr"},{"key":"key\n\t\t\t\t20180306121508_CIT0012","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.vaccine.2016.04.016","article-title":"Factors associated with incomplete or delayed vaccination across countries: a systematic review","volume":"34","author":"Tauil","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121508_CIT0013","first-page":"963","article-title":"Deconstructing social resistance to pulse polio campaign in two North Indian districts","volume":"46","author":"Chaturvedi","year":"2009","journal-title":"Indian Pediatr"},{"key":"key\n\t\t\t\t20180306121508_CIT0014","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2471\/BLT.12.106260","article-title":"Parental perceptions surrounding polio and self-reported non-participation in polio supplementary immunization activities in Karachi, Pakistan: a mixed methods study","volume":"90","author":"Khowaja","year":"2012","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180306121508_CIT0015","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/infdis\/jiu318","article-title":"Progress toward poliomyelitis eradication in Nigeria","volume":"210 Suppl 1","author":"Ado","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2458-14-232","article-title":"Factors associated with non-utilization of child immunization in Pakistan: evidence from the demographic and health Survey 2006\u201307","volume":"14","author":"Bugvi","year":"2014","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t20180306121508_CIT0017","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/infdis\/jiu288","article-title":"An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign\u2013Katsina State, Nigeria","volume":"210 Suppl 1","author":"Michael","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0018","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/infdis\/jiu022","article-title":"Polio eradication initiative in Afghanistan, 1997\u20132013","volume":"210","author":"Simpson","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0019","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1016\/j.vaccine.2016.05.069","article-title":"Reaching the unreached with polio vaccine and other child survival interventions through partnership with military in Angola","volume":"34","author":"Fekadu","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121508_CIT0020","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/infdis\/jiv589","article-title":"Revised household-based microplanning in polio supplemental immunization activities in Kano State, Nigeria. 2013\u20132014","volume":"213","author":"Gali","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0021","doi-asserted-by":"crossref","first-page":"6837824","DOI":"10.1155\/2016\/6837824","article-title":"Eradication and current status of poliomyelitis in pakistan: ground realities","volume":"2016","author":"Ghafoor","year":"2016","journal-title":"J Immunol Res"},{"key":"key\n\t\t\t\t20180306121508_CIT0022","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/oxfordjournals.aje.a008836","article-title":"Circulation of poliovirus during the poliomyelitis outbreak in the Netherlands in 1992\u20131993","volume":"143","author":"ConynvanSpaendonck","year":"1996","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180306121508_CIT0023","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1542\/peds.114.1.187","article-title":"Children who have received no vaccines: who are they and where do they live?","volume":"114","author":"Smith","year":"2004","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180306121508_CIT0024","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/infdis\/jit843","article-title":"Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination","volume":"210","author":"Kisjes","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2807\/1560-7917.ES.2016.21.16.30210","article-title":"Lessons learnt to keep Europe polio-free: a review of outbreaks in the European Union, European Economic Area, and candidate countries, 1973 to 2013","volume":"21","author":"Derrough","year":"2016","journal-title":"Eurosurveillance"},{"key":"key\n\t\t\t\t20180306121508_CIT0026","first-page":"29","article-title":"Routine immunization in children and unsatisfactory polio campaigns; a cross sectional survey conducted at Darul Sehat Hospital, Karachi","volume":"21","author":"Bham","year":"2016","journal-title":"Ann Abbasi Shaheed Hosp Karachi Med Dent Coll"},{"key":"key\n\t\t\t\t20180306121508_CIT0027","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180306121508_CIT0028","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12879-015-1112-8","article-title":"An economic analysis of poliovirus risk management policy options for 2013\u20132052","volume":"15","author":"Duintjer Tebbens","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0029","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12879-015-1115-5","article-title":"Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs","volume":"15","author":"Duintjer Tebbens","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12879-016-1536-9","article-title":"Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation","volume":"16","author":"Duintjer Tebbens","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0031","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12879-016-1537-8","article-title":"Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use","volume":"16","author":"Duintjer Tebbens","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0032","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix128","article-title":"Lessons from globally-coordinated cessation of serotype 2 oral poliovirus vaccine for the remaining serotypes","author":"Thompson","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0033","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/risa.12044","article-title":"Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180306121508_CIT0034","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2334-14-45","article-title":"The potential impact of expanding target age groups for polio immunization campaigns","volume":"14","author":"Duintjer Tebbens","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0035","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.vaccine.2015.02.013","article-title":"Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses","volume":"33","author":"Thompson","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121508_CIT0036","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/infdis\/jit844","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0037","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jit834","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0038","doi-asserted-by":"crossref","first-page":"e0130123","DOI":"10.1371\/journal.pone.0130123","article-title":"Combinations of quality and frequency of immunization activities to stop and prevent poliovirus transmission in the high-risk area of northwest Nigeria","volume":"10","author":"Duintjer Tebbens","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306121508_CIT0039","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/infdis\/jiu674","article-title":"Modeling options to manage type 1 wild poliovirus imported into Israel in 2013","volume":"211","author":"Kalkowska","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/003335491212700104","article-title":"Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response","volume":"127","author":"Thompson","year":"2012","journal-title":"Public Health Rep"},{"key":"key\n\t\t\t\t20180306121508_CIT0041","first-page":"17","article-title":"The potential impact of expanding target age groups for polio immunization campaigns","volume":"14","author":"Tebbens","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0042","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.1323688111","article-title":"The role of older children and adults in wild poliovirus transmission","volume":"111","author":"Blake","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180306121508_CIT0043","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1371\/journal.pone.0113538","article-title":"Quantifying the impact of expanded age group campaigns for polio eradication","volume":"9","author":"Wagner","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306121508_CIT0044","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121508_CIT0045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121508_CIT0046","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180306121508_CIT0047","doi-asserted-by":"crossref","first-page":"e1005728","DOI":"10.1371\/journal.ppat.1005728","article-title":"Preventing vaccine-derived poliovirus emergence during the polio endgame","volume":"12","author":"Pons-Salort","year":"2016","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180306121508_CIT0048","first-page":"145","article-title":"Resurgence of wild poliovirus type 1 transmission and consequences of importation\u201421 previously polio-free countries, 2002\u20132005","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306121508_CIT0049","article-title":"Maintenance and intensification of bivalent oral poliovirus vaccine use prior to its coordinated global cessation","volume":"7","author":"Duintjer Tebbens","year":"2016","journal-title":"J Vaccin Vaccination"},{"key":"key\n\t\t\t\t20180306121508_CIT0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/infdis\/jit838","article-title":"Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation","volume":"210","author":"Duintjer Tebbens","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0051","article-title":"Costs and benefits of including inactivated in addition to oral poliovirus vaccine in outbreak response after cessation of oral poliovirus vaccine use","author":"Duintjer Tebbens","year":"2017","journal-title":"Med Decis Making Policy Pract"},{"key":"key\n\t\t\t\t20180306121508_CIT0052","doi-asserted-by":"crossref","first-page":"30408","DOI":"10.2807\/1560-7917.ES.2016.21.47.30408","article-title":"Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016","volume":"21","author":"Weil","year":"2016","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20180306121508_CIT0053","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S0950268816002302","article-title":"Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy","volume":"145","author":"Duintjer Tebbens","year":"2017","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180306121508_CIT0054","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/62.1.213","article-title":"Eradication and cessation of programmes","volume":"62","author":"Minor","year":"2002","journal-title":"Br Med Bull"},{"key":"key\n\t\t\t\t20180306121508_CIT0055","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121508_CIT0056","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4161\/21645515.2014.981115","article-title":"The polio endgame","volume":"10","author":"Minor","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180306121508_CIT0057","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0058","author":"Halsey"},{"key":"key\n\t\t\t\t20180306121508_CIT0059","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.coviro.2012.02.006","article-title":"Reaching the last one per cent: progress and challenges in global polio eradication","volume":"2","author":"Kew","year":"2012","journal-title":"Curr Opin Virol"},{"key":"key\n\t\t\t\t20180306121508_CIT0060","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/infdis\/jiv581","article-title":"The role of the polio program infrastructure in response to Ebola virus disease outbreak in Nigeria 2014","volume":"213","author":"Vaz","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0061","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/511285a","article-title":"Infectious disease: polio eradication hinges on child health in Pakistan","volume":"511","author":"Bhutta","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180306121508_CIT0062","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121508_CIT0063","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12879-016-1465-7","article-title":"Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame","volume":"16","author":"Duintjer Tebbens","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0064","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121508_CIT0065","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1473-3099(15)00094-8","article-title":"Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial","volume":"15","author":"Est\u00edvariz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0066","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(15)00237-8","article-title":"Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial","volume":"386","author":"Sutter","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121508_CIT0067","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121508_CIT0068","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121508_CIT0069","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12879-015-1116-4","article-title":"The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission","volume":"15","author":"Thompson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12879-015-0791-5","article-title":"Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination","volume":"15","author":"Kalkowska","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0071","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(14)60983-1","article-title":"Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine","volume":"384","author":"Thompson","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121508_CIT0072","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiv492","article-title":"Implementation of a systematic accountability framework in 2014 to improve the performance of the Nigerian Polio Program","volume":"213","author":"Tegegne","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0073","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1093\/infdis\/175.Supplement_1.S277","article-title":"Integrated disease control initiatives: polio eradication and neonatal tetanus elimination in Egypt","volume":"175","author":"Mansour","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121508_CIT0074","first-page":"321","article-title":"Poliomyelitis surveillance: the model used in India for polio eradication","volume":"78","author":"Banerjee","year":"2000","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180306121508_CIT0075","volume-title":"World population prospects. The 2015 revision. United Nations: New York, NY, 2016; Volume I: Comprehensive tables. 2015. Report ST\/ESA\/SER.A\/379","author":"Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_1\/S176\/24265059\/jix108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T17:15:32Z","timestamp":1520356532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_1\/S176\/3935072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":75,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,7,1]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix108","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,7,1]]}}}